fromZDNET1 month agoHealthUltrahuman's Blood Vision health assessment platform rolls out today - but it's not cheap
fromZDNET2 months agoWearablesUltrahuman's new AI tool can predict your risk for cancer, fatigue, and more - here's what it costs
fromZDNET2 months agoWearablesPredict your future health? Ultrahuman's new AI tool says it can - for $800/year
fromTechCrunch3 months agoNYC startupElizabeth Holmes' partner reportedly fundraising for new blood-testing startup | TechCrunch
fromZDNET1 month agoHealthUltrahuman's Blood Vision health assessment platform rolls out today - but it's not cheap
fromZDNET2 months agoWearablesUltrahuman's new AI tool can predict your risk for cancer, fatigue, and more - here's what it costs
fromZDNET2 months agoWearablesPredict your future health? Ultrahuman's new AI tool says it can - for $800/year
fromTechCrunch3 months agoNYC startupElizabeth Holmes' partner reportedly fundraising for new blood-testing startup | TechCrunch
NYC startupfromwww.mercurynews.com3 months agoFraudster Elizabeth Holmes' partner launches startup in same field where she failed: not Theranos 2.0'Billy Evans has launched a blood testing startup named Haemanthus, asserting no involvement from Elizabeth Holmes.
fromEntrepreneur3 months agoElizabeth Holmes' Partner Starts Blood Testing Company | EntrepreneurHaemanthus, incorporated in February 2024, focuses initially on animal tests for pet health care, intending to expand into human diagnostics in the future.NYC startup
NYC startupfromwww.theguardian.com3 months agoElizabeth Holmes's partner reportedly raises millions for blood-testing startupBilly Evans, partner of Elizabeth Holmes, is launching a blood-testing startup similar to Theranos, despite the latter's notorious downfall.
Mental healthfromNature4 months agoFaster, cheaper, better: the rise of blood tests for Alzheimer'sBlood-based tests are transforming Alzheimer's diagnostics, enabling early detection and treatment.
fromwww.bbc.com4 months agoBlood test firm blamed for 'catalogue of disasters'Synnovis is under scrutiny for unreliable blood-testing services, causing patient distress and operational issues for healthcare providers.
